John S. Ikonomidis, MD, PhD, Associate Professor, Cardiothoracic Surgery, Medical University of South Carolina, discusses the risk of mortality associated with aortic valve replacement. References and Resources Dewey…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses volumetric arc therapy. References and Resources…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses the licensing and education for the naturopathic profession. References and Resources Parkman CA. A look at…
James B. McGuire, DPM, PT, Director, Leonard Abrams Center for Advanced Wound Healing of the Foot and Ankle Institute, Department of Podiatric Medicine and Orthopedics, Temple University School…
Victor Kim, MD, Assistant Professor of Medicine, Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses the effects of statins in patients with COPD using the…
A recent study shows that malignant high-grade PINs have a greater expression of PTOV1 (prostate tumor overexpressed-1) compared with benign lesions, and as expression of PTOV1 decreased, so…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses the risks of using both complimentary medicine and conventional medicine simultaneously. References and Resources Eliott JA,…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses complementary therapy. References and Resources Wheeler P, Hyland ME. Dispositional predictors of complementary medicine and vitamin…
Kathya M. Zinszer, DPM, Associate Professor of Podiatric Medicine, Temple University School of Podiatric Medicine, discusses heel pain syndrome. References and Resources Pribut SM. Current approaches to the…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses complementary therapy with the treatment of cancer. References and Resources Eliott JA, Kealey CP, Olver IN.…
In a recent study, fluoxetine (Prozac) decreased progression of relapsing-remitting MS in a small placebo-controlled study, but the effect lasted only a few months. References and Resources Mostert…
Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses the future of testing for early stage…
